What Allergan Is Buying and Shedding to Gain a Better Position (Retrosense Therapeutics)
When Actavis Plc. acquired Allergan Inc. in March 2015, the company changed its name from Actavis Plc. to Allergan Plc (AGN)…In September 2016, Allergan announced the acquisition of Retrosense Therapeutics, a gene therapy company, in order to strengthen its Eye Care pipeline by Retrosense’s first-in-class technology RST-001 for the potential treatment of retinitis pigmentosa. Read more >>